Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CETP | P11597 | 2/20 | 0.32 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.32 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29606519 | 0.87 | ALDH1A1 (0.36) | — | |
| SCHEMBL31568878 | 0.87 | ALDH1A1 (0.36) | — | |
| SCHEMBL462590 | 0.87 | ALDH1A1 (0.36) | — | |
| SCHEMBL15119998 | 0.82 | ALDH1A1 (0.33) | — | |
| SCHEMBL14782194 | 0.79 | AKR1C3 (0.37) | CETPAKR1C3AKR1C2 | |
| SCHEMBL29378428 | 0.79 | AKR1C3 (0.37) | CETPAKR1C3AKR1C2 | |
| SCHEMBL470718 | 0.78 | PTGS2 (0.36) | CETP | |
| SCHEMBL19469283 | 0.76 | AKR1C3 (0.35) | CETPAKR1C3AKR1C2 | |
| SCHEMBL16450515 | 0.76 | CETP (0.35) | CETPAKR1C3AKR1C2 | |
| SCHEMBL16248038 | 0.74 | CETP (0.33) | CETPAKR1C3AKR1C2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260109698-A1 | MALT-1 MODULATORS | EXSCIENTIA AI LIMITED (GB) | 2026-04-23 | — | — | US | disclosed |
| US-20250051327-A1 | MALT-1 MODULATORS | RECURSION PHARMACEUTICALS, INC. | 2025-02-13 | — | — | US | disclosed |
| EP-4247492-A1 | MALT-1 MODULATORS | Exscientia Al Limited (GB) | 2023-09-27 | — | — | EP | disclosed |
| WO-2022106857-A1 | MALT-1 MODULATORS | Exscientia Limited (GB) | 2022-05-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250051327-A1 | MALT-1 MODULATORS | MALT1, BCL6, BCL9 | CETP 940/4885AKR1C3 3641/4885AKR1C2 3361/4885 |
| US-20260109698-A1 | MALT-1 MODULATORS | MALT1, BCL6, BCL3 | CETP 3457/4885AKR1C3 1981/4885AKR1C2 2825/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.